Trademark: 88730272
Status Date
Monday, February 19, 2024
Filing Date
Tuesday, December 17, 2019
Published for Opposition
Tuesday, November 24, 2020
Abandoned Date
Monday, February 19, 2024
5 pharmaceutical preparations for the treatment of neurodegenerative diseases, cancer, HIV, hematopoietic disease and disorders, blood disorders, cardiovascular diseases and disorders, genetic diseases and disorders, liver diseases and disorders, infectious diseases, immune system related diseases and disorders, metabolic diseases and disorders, kidney diseases and disorders, and reproductive diseases and disorders; pharmaceutical preparations comprised of small molecules in the nature of organic compounds that target RNA for use in medical treatments via the induction or inhibition of gene expression; pharmaceutical preparations that contain RNA-targeting small molecule therapeutics for the treatment of neurodegenerative diseases, cancer, HIV, hematopoietic disease and disorders, blood disorders, cardiovascular diseases and disorders, genetic diseases and disorders, liver diseases and disorders, infectious diseases, immune system related diseases and disorders, metabolic diseases and disorders, kidney diseases and disorders, and reproductive diseases and disorders
42 research and development services in the field of pharmaceuticals
Feb 20, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 19, 2024
Abandonment - No Use Statement Filed
Nov 13, 2023
Assigned To Examiner
Jun 29, 2023
Assigned To Examiner
Jun 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2023
Sou Extension 5 Granted
May 31, 2023
Sou Extension 5 Filed
Jun 7, 2023
Case Assigned To Intent To Use Paralegal
May 31, 2023
Sou Teas Extension Received
Dec 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 16, 2022
Sou Extension 4 Granted
Dec 16, 2022
Sou Extension 4 Filed
Dec 16, 2022
Sou Teas Extension Received
Jun 18, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 16, 2022
Sou Extension 3 Granted
Jun 16, 2022
Sou Extension 3 Filed
Jun 16, 2022
Sou Teas Extension Received
Nov 25, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 23, 2021
Sou Extension 2 Granted
Nov 23, 2021
Sou Extension 2 Filed
Nov 23, 2021
Sou Teas Extension Received
May 22, 2021
Notice Of Approval Of Extension Request E-Mailed
May 20, 2021
Sou Extension 1 Granted
May 20, 2021
Sou Extension 1 Filed
May 20, 2021
Sou Teas Extension Received
Jan 19, 2021
Noa E-Mailed - Sou Required From Applicant
Nov 24, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 24, 2020
Published For Opposition
Nov 4, 2020
Notification Of Notice Of Publication E-Mailed
Oct 20, 2020
Approved For Pub - Principal Register
Oct 1, 2020
Teas/Email Correspondence Entered
Sep 30, 2020
Correspondence Received In Law Office
Sep 30, 2020
Teas Response To Office Action Received
Apr 1, 2020
Notification Of Non-Final Action E-Mailed
Apr 1, 2020
Non-Final Action E-Mailed
Apr 1, 2020
Non-Final Action Written
Mar 16, 2020
Notification Of Non-Final Action E-Mailed
Mar 16, 2020
Non-Final Action E-Mailed
Mar 16, 2020
Non-Final Action Written
Mar 16, 2020
Assigned To Examiner
Dec 20, 2019
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
